Skip to main content
Figure 5 | Arthritis Research & Therapy

Figure 5

From: Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis

Figure 5

Estradiol and estrone levels are increased in serum of patients with diffuse cutaneous systemic sclerosis. Dot plots of serum levels of estradiol and estrone in patients with diffuse cutaneous systemic sclerosis (SSc) and healthy controls. Measurements were made using 68 patients with SSc and 35 healthy controls. Differences in estradiol levels were not significant whereas estrone levels were statistically significant (P = 0.002).

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us